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SUMMARY
The purpose of this study was to compare the occurrence of tuberculosis (TB) and the outcome
of treatment between TB patients living in urban and rural areas. Cases of TB reported from
2001 to 2003 in England and Wales were assigned to a rural or urban area classiﬁcation. The
outcome of interest, non-completion of treatment, was investigated to determine the odds ratio
for urban vs. rural residence. The eﬀects of age, sex, ethnicity, place of birth, time since arrival
in the United Kingdom, disease site, isoniazid resistance and previous diagnosis were adjusted
for by multivariable logistic regression. Crude odds ratios showed a signiﬁcantly higher level of
treatment non-completion in rural areas. These results became non-signiﬁcant (OR 1.02, 95% CI
0.83–1.26, P=0.82) after adjusting for the confounding eﬀects of ethnic group and age. In
England and Wales residence in a rural location is not an independent determinant of TB
treatment outcome failure.
INTRODUCTION
The burden of disease in urban populations is gener-
ally considered to be greater than in rural popu-
lations. The evidence on quality of care, however,
suggests that service accessibility is poorer in rural
areas [1, 2]. While health services in urban settings
may be within relatively easy reach, patients in rural
areas often have to travel long distances. It is not
known whether levels of access to tuberculosis (TB)
services diﬀer between urban and rural areas in the
United Kingdom.
There are reasons why the outcome of care may
be worse in urban or rural areas. Variation in the
occurrence of TB between urban and rural areas
has been reported from various countries [3, 4]. In
the United Kingdom, TB is more common in urban
areas [5]. The higher case load in urban areas may
result in services based in cities generally having
greater clinical experience in the management of
TB when compared with rural services which may
aﬀect the overall quality of care available to patients
in rural settings. In contrast, many TB patients in
urban settings are from highly deprived communities.
Social disadvantage in urban areas may contribute
to a poorer outcome. This study was undertaken to
determine whether a diﬀerence exists in treatment
completion rates between urban and rural areas and to
investigate the factors associated with any variation in
outcome.
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MATERIAL AND METHODS
Study subjects, deﬁnitions and data sources
All patients reported to the national enhanced TB
surveillance system from 2001 to 2003 in England
and Wales were eligible for inclusion. TB cases in-
clude all patients whose diagnosis was conﬁrmed by
bacteriological culture or those who have clinical/
radiological/histopathological features suggestive of
TB and the clinician had taken the decision to treat
the patient with a full course of anti-TB therapy.
Outcome data were collected 12 months after the date
of notiﬁcation or start of treatment. Outcome was
categorized as either treatment completed or treat-
ment not completed. The ‘treatment not completed’
category includes patients whose reported outcome
was death, lost to follow-up, transferred out, still
on treatment, treatment stopped or ‘unknown’. The
residential postcodes of all cases with an outcome
reported were geo-coded. Cases were assigned to
a rural or urban area based on the Rural and Urban
Classiﬁcation 2004 Oﬃce of National Statistics
(ONS) (see Fig.). Data from the 2001 census were
used to derive population denominator estimates for
urban and rural areas.
Patients with multidrug-resistant disease were ex-
cluded from the analysis because current treatment
regimens recommend a course of therapy of at least
18 months for any patient with rifampicin resistance.
Information on the treatment outcome of patients
at 18 or 24 months is currently not collected by the
national TB surveillance system.
Analysis
The relative risk of TB in urban compared to rural
areas was determined. The outcome of interest, non-
completion of treatment within 12 months of starting
treatment or notiﬁcation, was investigated by logistic
regression to determine odds ratios for urban vs. rural
residence. A multivariable model was ﬁtted control-
ling for the eﬀect of all factors signiﬁcant in the
univariable analysis. Bivariable analysis was used to
sequentially examine the confounding eﬀect of age,
sex, ethnic group, place of birth/time since arrival in
the United Kingdom, disease site, drug resistance and
previous diagnosis.
RESULTS
A total of 19 836 cases were reported. Of these an
outcome was reported on 16 784 (85%) patients. A
residential postcode was available for 16 109 cases
(96%) and they were mapped to a rural or an urban
area. The median age of the population was 36 years
(interquartile range 26–55 years). The majority of
cases lived in urban areas (96.7%), were male
(54.9%), of Indian, Pakistani, Bangladeshi (36.8%),
or black African (21.5%) ethnicity and born outside
the United Kingdom (68.5%).
The rate of TB in urban areas was 6.3-fold higher
compared to rural areas. Forty-ﬁve per cent of cases
living in rural areas did not complete treatment
compared with 26% of cases in urban areas. Crude
odds ratios [OR 1.72, 95% conﬁdence interval (CI)
1.42–2.07, P<0.001] showed a signiﬁcantly higher
treatment non-completion level in rural areas com-
pared to cases reported in urban areas.
Table 1 shows the results of univariable and
multivariable logistic regression analysis. The eﬀect
was non-signiﬁcant (OR 1.02, 95% CI 0.83–1.26,
P=0.82) in the multivariable analysis after control-
ling for age, sex, ethnicity, time since arrival in the
United Kingdom, disease site, isoniazid resistance
and previous diagnosis. Bivariable analysis showed
that ethnic group and age were the greatest eﬀect
modiﬁers with the urban–rural odds ratio declining to
1.18 (95% CI 0.97–1.44, P=0.09) when adjusting for
ethnic group, 1.29 (95% CI 1.06–1.57, P=0.01) when
adjusting for age and 1.07 (95% CI 0.88–1.31,
P=0.49) when adjusting for both. Table 2 shows a
breakdown of outcome categories for cases that have
not completed treatment by urban–rural location.
A large proportion of these cases die within 1 year of
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Fig. Oﬃce of National Statistics classiﬁcation of urban and rural areas. (Source : Oﬃce of National Statistics.)
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Table 1. Determinants of non-completion of treatment in cases reported in England and Wales in 2001–2003
Case characteristic
Not
completed Completed
Univariable analysis
for non-completion
of treatment
Multivariable analysis
for non-completion of
treatment
n n OR (95% CI) P value OR (95% CI) P value
Total 3578* 13 206* — — — — — —
Location (n=16 109) <0.001 0.86
Urban 3196 12 385 Ref. Ref.
Rural 162 366 1.72 (1.42–2.07) 1.02 (0.83–1.25)
Sex (n=16 769) <0.001 <0.001
Male 2170 7042 Ref Ref.
Female 1405 6152 0.74 (0.69–0.80) 0.78 (0.72–0.85)
Age (n=16 781) <0.001 <0.001
0–14 yr 111 871 0.61 (0.50–0.75) 0.69 (0.55–0.86)
15–44 yr 1684 8082 Ref. Ref.
45–64 yr 698 2545 1.32 (1.19–1.45) 1.36 (1.21–1.53)
o65 yr 1084 1706 3.05 (2.78–3.34) 3.02 (2.69–3.39)
Place of birth (n=16 784) <0.001 <0.001
United Kingdom 1201 3643 Ref. Ref.
Abroad (entry<1 yr) 282 756 1.13 (0.97–1.32) 1.80 (1.48–2.18)
Abroad (entry 1–4 yr) 592 2998 0.60 (0.54–0.67) 1.03 (0.88–1.20)
Abroad (entry 5–9 yr) 156 1081 0.44 (0.37–0.52) 0.74 (0.60–0.92)
Abroad (entryo10 yr) 482 2506 0.58 (0.52–0.66) 0.78 (0.66–0.91)
Abroad (date entry
unknown)
429 1252 1.04 (0.91–1.18) 1.46 (1.24–1.72)
UK status unknown 436 970 1.36 (1.20–1.55) 1.44 (1.22–1.68)
Ethnic group (n=16 784) <0.001 <0.001
White 1319 2942 Ref. Ref.
Black Caribbean 102 379 0.60 (0.48–0.75) 0.80 (0.62–1.03)
Black African 680 2926 0.52 (0.47–0.58) 0.86 (0.73–1.02)
Indian, Pakistani,
Bangladeshi
988 5190 0.42 (0.39–0.47) 0.64 (0.55–0.74)
Chinese 41 179 0.51 (0.36–0.72) 0.73 (0.50–1.08)
Other ethnic groups 346 1374 0.56 (0.49–0.64) 0.84 (0.70–1.00)
Unknown 102 216 1.05 (0.83–1.34) 1.13 (0.84–1.51)
Previous history of
tuberculosis (n=16 784)
<0.001 0.007
Previous tuberculosis 341 868 1.59 (1.39–1.81) 1.22 (1.06–1.41)
No previous
tuberculosis
2476 10 011 Ref. Ref.
Unknown 761 2327 1.32 (1.20–1.45) 1.17 (1.05–1.29)
Site of disease
(n=16 627)
<0.001 <0.001
Pulmonary 2378 7414 1.55 (1.43–1.68) 1.27 (1.16–1.39)
Extra-pulmonary 1171 5664 Ref. Ref.
Isoniazid susceptibility
results (n=16 784)
<0.001 <0.001
Isoniazid resistant 246 409 2.28 (1.93–2.69) 2.80 (2.34–3.36)
Isoniazid susceptible 1785 6762 Ref Ref
Culture-positive
resistance unknown
199 596 1.26 (1.07–1.50) 1.18 (0.98–1.41)
Culture not positive 1348 5439 0.94 (0.87–1.02) 1.00 (0.92–1.09)
OR, Odds ratio ; CI, conﬁdence interval.
* Note diﬀerences between totals (3578 and 13 206) and totals by case characteristics are due to missing information.
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diagnosis in both urban and rural areas. There is
also a larger proportion of cases in urban areas whose
ﬁnal outcome is not really known (such as lost to
follow-up or transferred out) compared to those in
rural areas.
DISCUSSION
TB is more common in urban compared to rural
areas in England and Wales. This picture is similar
to most low-incidence countries [6] and some high-
incidence countries [3]. However, relatively higher
incidence has been reported in rural populations
in other high burden countries [4]. Our analysis
shows that rural location is not an independent
determinant of failure to complete TB treatment.
The observed association in the univariable analysis
was probably due to the confounding eﬀects of
age and ethnicity. Other factors known to predict
non-completion of treatment such as isoniazid resist-
ance and male gender were shown to be associated
with poor outcome [7]. In addition, recent immigrants
(<1 year since arrival) appear to have a lower
treatment completion rate. This may be related to the
higher proportion of such individuals being lost to
follow-up or may reﬂect other diﬀerences in access to
services.
Death is a common cause of treatment failure
especially in the elderly white population living
in rural areas. Mortality in many of these patients
may be incidental to rather than the result of TB
disease, partly explaining the confounding eﬀect
of age on the association. This contrasts with the
higher proportion of young ethnic minority popu-
lations living in urban locations with lower mortality
rates.
Previous studies have used place of residence and
distance from treatment centre as a proxy measures
of access to care [8–11]. Neither of these, however,
may be an appropriate indicator. Access to care and
treatment outcome is determined by a complex inter-
play of patient and health-provider-related factors
including patient health belief model, signiﬁcant
others, language, socioeconomic status and avail-
ability of local health services [12].
These results should be interpreted with caution
bearing in mind the following limitations. A number
of potential confounding factors were examined
and age and ethnic group found to explain the ob-
served diﬀerence. The eﬀect of deprivation requires
further investigation in view of the known eﬀects ofT
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socioeconomic disadvantage on TB treatment out-
come. Homeless people in particular are known to
experience poor treatment completion rates [7] and
are more likely to be resident in a deprived urban
setting. The collection of information on home-
lessness and other socioeconomic factors will improve
understanding of the observed variations in treatment
completion rates. Furthermore, information on
changes in residence during therapy or duration of
treatment was not available.
The information used for the analysis was derived
from routine surveillance data. A proportion of cases,
therefore, did not have an outcome reported and an
assumption was made that the treatment completion
rate in these patients is not diﬀerent from the rate
in those with an outcome reported. The proportion
of patients without an outcome reported was 15%,
suggesting that this may be a potential source of bias.
Similarly, some cases had missing data on residential
postcode and were assumed not to diﬀer from those
with information on location. Patients living in urban
areas are more likely have complex social needs due
to homelessness, imprisonment and problem drug
use that have previously been associated with poor
treatment outcome [7]. These characteristics could
lower the likelihood of reporting residential postcode
leading to a proportion of patients with an adverse
outcome being excluded from the analysis. Residen-
tial postcode was, however, available for 96% of
cases reducing the potential magnitude of this eﬀect.
In addition, despite the high prevalence of TB in
socially complex groups, they only account for 17%
of the overall proportion of reported TB patients in
London [13].
Internationally there is some debate regarding the
most appropriate classiﬁcation of rural and urban
residence [14]. The ONS classiﬁcation which uses the
size of settlements to classify areas was selected for
this study because it is widely used, readily available,
and applicable to the United Kingdom.
Living in a rural location is not an independent
determinant of failure to complete TB treatment
in England and Wales. Other factors such as the
age of patients and ethnicity better explain the
observed diﬀerence in outcome by place of residence.
Further assessment of diﬀerences in outcome be-
tween hospitals comparing high TB burden and
low-incidence areas and an investigation into the
role of deprivation and drug resistance will im-
prove our understanding of factors associated with
outcome.
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